JP2005518354A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518354A5
JP2005518354A5 JP2003545335A JP2003545335A JP2005518354A5 JP 2005518354 A5 JP2005518354 A5 JP 2005518354A5 JP 2003545335 A JP2003545335 A JP 2003545335A JP 2003545335 A JP2003545335 A JP 2003545335A JP 2005518354 A5 JP2005518354 A5 JP 2005518354A5
Authority
JP
Japan
Prior art keywords
component
agents
pharmaceutical composition
codrug
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003545335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/037035 external-priority patent/WO2003043657A1/en
Publication of JP2005518354A publication Critical patent/JP2005518354A/ja
Publication of JP2005518354A5 publication Critical patent/JP2005518354A5/ja
Abandoned legal-status Critical Current

Links

JP2003545335A 2001-11-19 2002-11-19 コドラッグを含有する医薬組成物 Abandoned JP2005518354A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33151201P 2001-11-19 2001-11-19
PCT/US2002/037035 WO2003043657A1 (en) 2001-11-19 2002-11-19 Topical delivery of codrugs

Publications (2)

Publication Number Publication Date
JP2005518354A JP2005518354A (ja) 2005-06-23
JP2005518354A5 true JP2005518354A5 (enExample) 2006-01-19

Family

ID=23294274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003545335A Abandoned JP2005518354A (ja) 2001-11-19 2002-11-19 コドラッグを含有する医薬組成物

Country Status (6)

Country Link
US (3) US20030118528A1 (enExample)
EP (1) EP1448231A1 (enExample)
JP (1) JP2005518354A (enExample)
AU (1) AU2002350207A1 (enExample)
CA (1) CA2467559A1 (enExample)
WO (1) WO2003043657A1 (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
CN1520297A (zh) * 2001-04-26 2004-08-11 ���ߵ���Ƶϵͳ��˾ 包含复合药物(codrugs)的缓释药物传递系统
IL158882A0 (en) * 2001-06-05 2004-05-12 Control Delivery Sys Inc Sustained-release analgesic compounds
IN2014DN10834A (enExample) * 2001-09-17 2015-09-04 Psivida Inc
WO2003043657A1 (en) * 2001-11-19 2003-05-30 Control Delivery Systems, Inc. Topical delivery of codrugs
US20030170286A1 (en) * 2001-12-10 2003-09-11 Paul Ashton Treatment of genitourinary tract disorders
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
WO2005009480A2 (en) * 2003-06-11 2005-02-03 Control Delivery Systems, Inc. Implants containing codrugs
US8267914B1 (en) * 2003-10-16 2012-09-18 University Of Notre Dame Du Lac Method and apparatus for AC electrospray
AU2004284080B2 (en) * 2003-10-24 2008-10-02 Adhesives Research, Inc. Disintegratable films for diagnostic devices
US9248146B2 (en) * 2003-10-24 2016-02-02 Adhesives Research, Inc. Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EP1744787A4 (en) * 2004-05-14 2011-04-06 Interface Biologics Inc POLYMER COUPLING AGENTS AND PHARMACEUTICALLY ACTIVE POLYMERS MANUFACTURED THEREOF
US20060135609A1 (en) * 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
WO2008115590A1 (en) * 2007-03-21 2008-09-25 Alza Corporation Apparatus and method for transdermal delivery of a benzodiazepine
EP2152359A2 (en) 2007-05-25 2010-02-17 Compex Medical S.A. Wound healing electrode set
BRPI0912820A2 (pt) 2008-05-20 2015-10-13 Neurogesx Inc pró-fármacos de relação hepatoprotetora de acetaminofeno
WO2010022326A2 (en) * 2008-08-22 2010-02-25 Us Worldmeds Llc Transdermal delivery of apomorphine using microneedles
US20100086581A1 (en) * 2008-10-07 2010-04-08 Ernest Bove Method for purpura reduction and prevention
WO2014144073A2 (en) * 2013-03-15 2014-09-18 Rutgers, The State University Of New Jersey Augmenting moieties for anti-inflammatory compounds
US11731991B2 (en) 2008-11-03 2023-08-22 Lehigh University Augmenting moieties for anti-inflammatory compounds
DE102009008256A1 (de) * 2009-02-10 2010-08-12 Lts Lohmann Therapie-Systeme Ag Prodrugs vom Typ N-hydroxylierter Amidine, Guanidine und/oder Aminohydrazone zur Applikation über die Haut
BRPI0900238A2 (pt) * 2009-02-12 2010-10-26 Arch Chem Inc composição antimicrobiana e processo para controle da contaminação microbiana em processos de fermentação alcóolica
PL2403482T3 (pl) 2009-03-04 2018-06-29 Emplicure Ab Preparat odporny na nadużywanie
PL2427177T3 (pl) 2009-05-08 2018-09-28 Emplicure Ab Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
WO2012083178A1 (en) 2010-12-17 2012-06-21 Neo Oncology Inc. Methods and devices for using isoperillyl alcohol
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
WO2012032337A2 (en) * 2010-09-07 2012-03-15 Orexo Ab A transdermal drug administration device
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
CN105025929A (zh) 2013-03-08 2015-11-04 阿勒根公司 环孢菌素a-类固醇缀合物
US9402912B2 (en) 2013-03-08 2016-08-02 Allergan, Inc. Antibiotic conjugates directly linked with steroid drugs
BR112015029920A2 (pt) * 2013-06-04 2017-07-25 Lts Lohmann Therapie Systeme Ag sistema de administração transdérmica
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
IL255290B2 (en) 2015-04-27 2024-01-01 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Substances that bind to EGF1 and their use in the treatment of inflammatory diseases and tumors
MX2018000611A (es) * 2015-07-15 2018-09-06 Celator Pharmaceuticals Inc Sistemas mejorados de entrega de nanoparticula.
US10286095B2 (en) 2015-09-11 2019-05-14 Olson Ip Technologies, Inc. Travel kit
EA037327B1 (ru) 2015-09-22 2021-03-12 Грейбуг Вижн, Инк. Соединения и композиции для лечения глазных расстройств
US11045520B2 (en) * 2016-03-22 2021-06-29 The General Hospital Corporation Compositions and methods for topical delivery of pharmaceutical agents
US20210369666A1 (en) * 2016-10-26 2021-12-02 Thessicar E. ANTOINE Devices and methods for the treatment of a zoonotic herpesvirus infection
AU2018240462C1 (en) 2017-03-23 2022-12-08 Graybug Vision, Inc. Drugs and compositions for the treatment of ocular disorders
CN111201040A (zh) 2017-05-10 2020-05-26 灰色视觉公司 用于医学疗法的缓释微粒及其悬浮液
WO2019148294A1 (en) * 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
US12473326B2 (en) 2019-02-01 2025-11-18 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
CN114599406A (zh) * 2019-07-10 2022-06-07 波纹疗法公司 包含二聚类固醇前药的表面涂层和可植入装置及其用途
US20220347305A1 (en) 2019-08-07 2022-11-03 Ripple Therapeutics Corporation Controlled release drug dimers
WO2021041800A1 (en) * 2019-08-30 2021-03-04 Remedy Diagnostics LLC Transdermal device comprising pain molecules
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
CN113332588B (zh) * 2021-05-26 2023-05-09 四川大学 用于口腔黏膜给药的尖端载药可溶性微针贴片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2999102A (en) * 1959-10-14 1961-09-05 Thomae Gmbh Dr K Bis-(steroid-21)-dicarboxylic acid esters
US3147183A (en) * 1962-04-16 1964-09-01 Boehringer Sohn Ingelheim Bis-(steroid-21)-dicarboxylic acid esters
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
TW225536B (enExample) * 1990-08-23 1994-06-21 Ciba Geigy Ag
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
WO1993020079A1 (en) * 1992-04-06 1993-10-14 Biosite Diagnostics Incorporated Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
MXPA02001857A (es) * 1999-08-24 2003-07-14 Cellgate Inc Composiciones y metodos para incrementar la entrega de drogas a traves y dentro de tejidos epiteliales.
FR2803849B1 (fr) * 2000-01-19 2002-04-19 Centre Nat Rech Scient Molecules chimeres formees de psoralene et de retinoide, leur procede de preparation, et leurs applications au traitement de pathologies de l'hyperproliferation cellulaire et notamment du psoriasis
US6306842B1 (en) * 2000-06-02 2001-10-23 Medinox, Inc. Protected forms of a combination of pharmacologically active agents and uses therefor
WO2003043657A1 (en) * 2001-11-19 2003-05-30 Control Delivery Systems, Inc. Topical delivery of codrugs
MXPA04006875A (es) * 2002-01-18 2004-12-06 Control Delivery Sys Inc Sistema de gel polimerico para suministro controlado de cofarmacos.

Similar Documents

Publication Publication Date Title
JP2005518354A (ja) コドラッグを含有する医薬組成物
JP5105697B2 (ja) コドラッグのコントロールデリバリ用ポリマー性ゲルシステム
JP5628467B2 (ja) 生体分解性徐放性ドラッグデリバリーシステム
US20040180036A1 (en) Salts of codrugs and uses related thereto
EP2123274B1 (en) Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
TW413637B (en) Preparation for percutaneous absorption
ES2549924T3 (es) Análogos de ácido araquidónico y métodos para tratamiento analgésico usando el mismo
PT1962817E (pt) Administração transdérmica de uma forma de sal de meptazinol
JP2014520817A (ja) カンナビノイド受容体結合剤、組成物および方法
US20230128252A1 (en) Pharmaceutical compositions
JPWO2006118173A1 (ja) 経皮吸収製剤
JP2005513050A (ja) 尿生殖路疾患の治療
TW200526272A (en) Suspension delivery system for the sustained and controlled local release of pharmaceuticals
WO2005009480A2 (en) Implants containing codrugs
JP2001270826A (ja) 皮膚疾患治療・予防用外用剤
JP6566707B2 (ja) 経皮唾液腺投与用の唾液分泌促進剤
JP3568881B2 (ja) 皮膚疾患治療用外用剤
ES2356563T3 (es) Administración transdérmica de meptazinol.
WO2019008472A1 (en) PHARMACEUTICAL COMPOSITIONS OF LIGNOCAINE HCL
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
JP2001089371A (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤
CN1842321B (zh) 生物蚀解性缓释递药系统
JP2001288082A (ja) 乾癬治療・予防用外用剤
HK1174895B (en) Arachidonic acid analogs and methods for analgesic treatment using same